Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LORAZEPAM , USP: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

Gender data not available for LORAZEPAM , USP.

Age Information

The average age of patients reporting adverse events with LORAZEPAM , USP is 60.8 years.

Geographic Distribution

The majority of adverse event reports for LORAZEPAM , USP originate from US.

Report Summary & Outcomes

11
Total Reports
11
As Primary/Secondary Suspect
0
Deaths Reported
0
Hospitalizations

Reporting Timeline

First adverse event report: 20120822. Most recent report: 20140110. View full timeline →

More About LORAZEPAM , USP

LORAZEPAM , USP Full Profile Reports by Year Drug Interactions